(IWF) Russell 1000 Growth - Overview
Etf: Large-Cap, Growth, Technology, Healthcare, Consumer Discretionary
Dividends
| Dividend Yield | 0.40% |
| Yield on Cost 5y | 0.69% |
| Yield CAGR 5y | 2.88% |
| Payout Consistency | 97.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.2% |
| Relative Tail Risk | 5.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | -5.75 |
| Character TTM | |
|---|---|
| Beta | 1.159 |
| Beta Downside | 1.114 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.36% |
| CAGR/Max DD | 1.10 |
Description: IWF Russell 1000 Growth January 27, 2026
The iShares Russell 1000 Growth ETF (IWF) seeks to replicate the performance of the Russell 1000 Growth Index by holding at least 80 % of its net assets in the index’s component securities. The remaining allocation may be used for cash, money-market holdings, or derivatives (futures, options, swaps) that the manager believes will improve tracking efficiency. Because the fund can concentrate its holdings, it is classified as non-diversified under SEC rules.
As of December 2025, IWF managed roughly **$70 billion** in assets, with an **expense ratio of 0.19 %** and a **distribution yield of about 0.7 %**. The top five holdings were Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Alphabet Class A (GOOGL) and Meta Platforms (META), together representing roughly **38 %** of the portfolio. Sector exposure was heavily weighted toward **Technology (≈45 %)**, followed by **Consumer Discretionary (≈20 %)** and **Health Care (≈15 %)**. Recent performance showed a **12 % total return YTD 2025**, outpacing the broader S&P 500, but the fund’s growth tilt makes it sensitive to **interest-rate expectations** and **U.S. GDP growth**, which historically affect valuation multiples for high-growth stocks.
Given these dynamics, a next logical step is to compare IWF’s risk-adjusted metrics against peers-**ValueRay’s sector-adjusted Sharpe and Sortino scores can provide that quantitative edge**.
What is the price of IWF shares?
Over the past week, the price has changed by -1.96%, over one month by -3.97%, over three months by -3.15% and over the past year by +11.09%.
Is IWF a buy, sell or hold?
What are the forecasts/targets for the IWF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 542.2 | 18.7% |
IWF Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 120.94b USD (120.94b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 120.94b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 120.94b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.19% (E(120.94b)/V(120.94b) * Re(10.19%) + (debt-free company))
Discount Rate = 10.19% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)